148 related articles for article (PubMed ID: 27590006)
1. MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer.
Vos MC; Hollemans E; Ezendam N; Feijen H; Boll D; Pijlman B; van der Putten H; Klinkhamer P; van Kuppevelt TH; van der Wurff AA; Massuger LF
J Ovarian Res; 2016 Sep; 9(1):53. PubMed ID: 27590006
[TBL] [Abstract][Full Text] [Related]
2. Emerging prognostic markers related to mesenchymal characteristics of poorly differentiated breast cancers.
Scimeca M; Antonacci C; Colombo D; Bonfiglio R; Buonomo OC; Bonanno E
Tumour Biol; 2016 Apr; 37(4):5427-35. PubMed ID: 26563370
[TBL] [Abstract][Full Text] [Related]
3. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
4. Alteration of epithelial-mesenchymal transition markers in human normal ovaries and neoplastic ovarian cancers.
Yi BR; Kim TH; Kim YS; Choi KC
Int J Oncol; 2015 Jan; 46(1):272-80. PubMed ID: 25310727
[TBL] [Abstract][Full Text] [Related]
5. CD44 regulates pancreatic cancer invasion through MT1-MMP.
Jiang W; Zhang Y; Kane KT; Collins MA; Simeone DM; di Magliano MP; Nguyen KT
Mol Cancer Res; 2015 Jan; 13(1):9-15. PubMed ID: 25566991
[TBL] [Abstract][Full Text] [Related]
6. Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer.
Mashita N; Yamada S; Nakayama G; Tanaka C; Iwata N; Kanda M; Kobayashi D; Fujii T; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Surg Oncol; 2014 Nov; 110(6):745-51. PubMed ID: 24975268
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis.
Sung WJ; Park KS; Kwak SG; Hyun DS; Jang JS; Park KK
Int J Clin Exp Pathol; 2015; 8(8):8997-9009. PubMed ID: 26464642
[TBL] [Abstract][Full Text] [Related]
8. Combination of epithelial-mesenchymal transition and cancer stem cell-like phenotypes has independent prognostic value in gastric cancer.
Ryu HS; Park DJ; Kim HH; Kim WH; Lee HS
Hum Pathol; 2012 Apr; 43(4):520-8. PubMed ID: 22018628
[TBL] [Abstract][Full Text] [Related]
9. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer.
Saito S; Okabe H; Watanabe M; Ishimoto T; Iwatsuki M; Baba Y; Tanaka Y; Kurashige J; Miyamoto Y; Baba H
Oncol Rep; 2013 Apr; 29(4):1570-8. PubMed ID: 23404221
[TBL] [Abstract][Full Text] [Related]
10. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer.
Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y
Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
[TBL] [Abstract][Full Text] [Related]
12. Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.
Kolijn K; Verhoef EI; van Leenders GJ
Oncotarget; 2015 Sep; 6(27):24488-98. PubMed ID: 26041890
[TBL] [Abstract][Full Text] [Related]
13. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
14. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
15. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
Bozhkova DM; Poryazova-Markova EG
Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
[TBL] [Abstract][Full Text] [Related]
16. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
[TBL] [Abstract][Full Text] [Related]
17. Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis.
Ryabtseva OD; Lukianova NY; Shmurakov YA; Polishchuk LZ; Antipova SV
Exp Oncol; 2013 Sep; 35(3):211-8. PubMed ID: 24084461
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-14 induces epithelial-to-mesenchymal transition in synovial sarcoma.
Liu M; Qi Y; Zhao L; Chen D; Zhou Y; Zhou H; Lv Y; Zhang L; Jin S; Li S; Zou H; Jia W; Wang C; Jiang J; Liang W; Pang L; Li F
Hum Pathol; 2018 Oct; 80():201-209. PubMed ID: 29935194
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin÷CD44 immunophenotype in the epithelial-mesenchymal transition of bladder urothelial carcinomas.
Stepan AE; Pirici D; Bălăşoiu M; Novac MB; Drocaş AI; Ciurea RN; Stepan D; Gheonea DI; Simionescu CE
Rom J Morphol Embryol; 2015; 56(1):85-91. PubMed ID: 25826491
[TBL] [Abstract][Full Text] [Related]
20. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
